MarketBeat Earnings
Codexis (NASDAQ:CDXS) Cut to "Sell" at Wall Street Zen
Wall Street Zen has downgraded Codexis (NASDAQ:CDXS) from "Hold" to "Sell," causing the stock to fall 2.5% to $1.56, significantly below its 12-month high. Despite beating quarterly earnings expectations with a smaller loss and higher revenue than anticipated, the biotechnology company remains unprofitable, with a negative net margin and projected full-year loss. Institutional investors and hedge funds hold …